The actions of thyroid hormones are mediated by binding to nuclear receptors, TRα and TRβ, that act as ligand-dependent transcription factors by association, generally as heterodimers with retinoid X receptors (RXRs), to hormone response elements (TREs) located in regulatory regions of target genes (1). TRs can also modulate expression of genes that do not contain a TRE by modulating the activity of other transcription factors and signaling pathways (2), including activator protein-1 (AP-1), cyclic AMP response element and nuclear factor-κB (NF-kB)-dependent pathways (3-7).
The actions of thyroid hormones are mediated by binding to nuclear receptors, TRα and TRβ, that act as ligand-dependent transcription factors by association, generally as heterodimers with retinoid X receptors (RXRs), to hormone response elements (TREs) located in regulatory regions of target genes (1) . TRs can also modulate expression of genes that do not contain a TRE by modulating the activity of other transcription factors and signaling pathways (2) , including activator protein-1 (AP-1), cyclic AMP response element and nuclear factor-κB (NF-kB)-dependent pathways (3) (4) (5) (6) (7) .
Studies with knockout (KO) mice for TRs obtained by homologous recombination have indicated that KO mice for α1 and β TR isoforms have different phenotypes (8) (9) (10) and that the double KO mice, surprisingly, survive (11) indicating that these receptors are not required for viability. Although these animals show extreme resistance to thyroid hormones, they exhibit a milder phenotype than hypothyroid mice, indicating divergent consequences for hormone versus receptor deficiency for some actions.
Although the skin is a target tissue for thyroid hormone action, no studies on the skin phenotype in TR K.O mice have been reported. TRα and TRβ mRNAs are present in the skin (12) (13) (14) (15) and these receptors can regulate either positively or negatively the expression of selected keratins in cultured cells (16) (17) (18) (19) . Clinical evidence (19) (20) (21) (22) (23) (24) (25) (26) (27) , as well as studies in hypothyroid mice and rats (28) (29) (30) , also suggest that thyroid hormones could be involved in epidermal proliferation and differentiation, hair growth and wound healing, besides affecting the function of dermal fibroblasts. A question emerging from these studies is how to distinguish between effects due to altered thyroid hormone levels and effects due to expression of specific TR isoforms.
The TR K.O mice represent an excellent model for the analysis of the role on these receptors in the skin and its response to hyperproliferative stimuli. Topical application of 12-Otetradecanolyphorbol-13-acetate (TPA) to mouse skin is a well-known model for induction of skin hyperproliferation and also promotes a strong inflammatory reaction that activates multiple immunostimulatory pathways. The skin response to TPA is associated with activation of several intracellular pathways, e.g. mitogen-activated protein kinases (MAPKs), AKT, NF-κB, STAT3 and AP-1, as well as an increase in the content chemical mediators, such as cytokines, chemokines, vasoactive peptides, prostaglandins, leukotrienes and nitric oxide, among others (31-34).
In this work we have investigated skin proliferation and inflammation, before and after TPA application, in mice lacking TRα1, TRβ or both genes, comparing these responses with those of hypothyroid animals to distinguish the specific contributions of receptor expression and activation. We found that TRs and thyroid hormones are required for skin homeostasis after TPA treatment and that both receptor genes contribute to attain a normal proliferative response to the tumor promoter. Reduced proliferation in animals lacking TRs correlates with increased expression of cyclin-dependent kinase inhibitors in the interfollicular epidermis, and with strongly reduced cyclin D1 expression in the keratinocytes of the basal layer. In addition, skins from TR KO mice show signs of inflammation with increased production of several pro-inflammatory cytokines, which is associated with enhanced phosphorylation of p65/NF-κB and STAT3 transcription factors. These results show a novel role for TRs in the skin response to proliferative signals and demonstrate that these receptors act as endogenous inhibitors of cutaneous inflammation. (11) and used for the studies. Wild-type mice were made hypothyroid (hT) by treatment with 0.02% methymazole and 0.1% sodium perchlorate in the drinking water (35) . Treatment started when animals were 1 month old and was continued for 4 months. Dorsal skins were shaved and exhaustively depilated with hair removing cream 24 h before the treatment with TPA (obtained from Sigma Chemical Co., St. Louis, MO). TPA (12 µg) was applied topically twice (at days 1 and 3) and mice were sacrificed at day 4 or 7. In the control group, animals were treated with vehicle (acetone) only. At the end of the experiments, skin was excised and either frozen to obtain RNA and protein or fixed for immunohistochemical analysis. Between three and six animals per experimental group were examined and most experiments were repeated at least 3 times.
EXPERIMENTAL PROCEDURES

Animals and Treatments-
Histological and Immunohistochemical
Analysis-Skin samples were fixed with paraformaldehyde or ethanol and embedded in paraffin. Skin sections (4µm) were stained with H&E or processed for immunohistochemistry. Immunohistochemistry was performed using standard protocols on deparaffinized sections as previously described (36) . The slides were microwaved with citrate buffer after deparaffinization to enhance the staining. Sections were preincubated for 30 min with 5% horse serum in PBS and incubated with primary antibodies (dilution 1:100) at 4°C overnight and with a secondary antibody for 2 h at room temperature. They were resolved with avidin-biotin peroxidase complex using Vectastain ABC kit (Vector Laboratories), and were revealed with diaminodenzidine (DAB kit, Vector Laboratories) and counterstained with hematoxylin. Slides were mounted and analyzed by light microscopy (Leica DM RXA2), and microphotographs were taken. Frozen sections of skin were used to detect by immunofluorescence K5, K10 and loricrin, as well as dermal inflammatory cells. T lymphocytes were detected by expression of CD3ε, T and B lymphocytes by expression of CD45, and macrophages by expression of CD11b/Mac1.
BrdU
LabelingEpithelial cell proliferation was measured by ip injection of bromodeoxyuridine (BrdUrd; 0.1 mg/g weight in 0.9% NaCl), 1 h prior sacrifice. BrdU incorporation was detected by immunohistochemistry of paraffinembedded sections using a mouse antiBrdU monoclonal antibody (Roche, no. 1170376). The number of BrdU-positive and total basal keratinocytes cells was counted in at least five areas from 5 animals of each experimental group. The mean±SD percentage of proliferating over total basal cells (>200) was then estimated as reported in (36 Cytokine and Chemokine Quantification-R&D Systems Mouse Cytokine Array, Panel A (Catalog # ARY006) was used to simultaneously detect the levels of 40 different cytokines and chemokines in 1 mg of whole-cell protein extracts obtained from skins from 3 animals per group and following the manufacturer specifications. Samples were analyzed in duplicate, and signals were detected by chemiluminiscence and were quantitated by scanning the X-ray films after different exposures (between 1 and 10 min) with Quantity One-4.6.6 (Basic mode) 1D Analysis Software BIO-RAD 200. Electrophoretic mobility shift assays (EMSA)-EMSAs were performed by incubating total or nuclear cell extracts from mouse skin with a labeled doublestranded oligonucleotide corresponding to consensus AP-1 (5'-CGCTTGATG ACTCAGCCGGAA-3') or NF-κB (5'-GATCCAACGGCAGGGGAATTCCCCT CTCCTTA-3') sites. Complexes were separated on 5.5% native polyacrylamide gels in 0.25x Tris-borate-EDTA buffer, dried, and exposed to Hyperfilm-MP (Amersham) at -70 C.
Primary cultures-Primary keratinocytes were derived from newborn double KO mice and the corresponding wild-type controls. Tails from each pup were used for genotyping. Skin was removed, and epidermis was obtained by trypsinization. Cells were plated in Eagle's minimal essential medium (BioWhittaker, Inc.) supplemented with 4% Chelex-treated foetal bovine serum and 0.2 mM Cl 2 Ca. After 15 h, cells were transferred to medium containing 0.05 mM Cl 2 Ca. To analyze proliferation, cells were incubated for 1h with 10 mM BrdU. Quantitative real-time PCR assays-Total RNA was extracted from keratinocytes using Tri Reagent (Sigma). mRNA levels were analyzed in triplicate samples by quantitative RT-Q-PCR. RT was performed with 2 µg of RNA following specifications of SuperScript™ FirstStrand Synthesis System (Invitrogen Life Technologies). The primers used were: 5'-GAACTGG CAGAAGAGGCACT-3' (forward) and 5'-AGGGTCTGGGCCATA GAACT-3' (reverse) for TNFα; 5'-GGAA TCACCATGCCCTCTA-3' (forward) and 5'-TGGCTGTCTTTGTGAGATGC-3' (reverse) for S100A8 and 5'-TCATCGA CACCTTCCATCAA-3' (forward) and 5'-GTCCTGGTTTGTCCAGGT-3' (reverse) for S100A9. PCRs reactions were performed using a MX3005P instrument (Stratagene) and detected with Sybr Green. Data analysis was done using the comparative CT method and data were corrected with the GPDH mRNA levels obtained with primers 5'-ACACTGCATGCCATCACTGCC-3' (forward) and 5'-GCCTGCTTCACCAC CTTCTTG-3' (reverse). Statistic analysis-Differences with respect to wild-type animals were assessed by using the t test, with statistical significance when P < 0.05. In the figures *p <0,05; **p<0,01 and *** p<0,001.
The skin of TRα1
-/-/TRβ -/-double knockout (KO) mice appeared to have a normal morphology ( Fig. 1 and Supplementary Fig. 1 ) and no overt differentiation alterations were observed, since expression and distribution of keratin 10 and loricrin was normal in TR deficient mice ( Supplementary Fig.2 ). However, BrdU incorporation analysis in paraffin sections incubated with an anti-BrdU antibody demonstrated a reduced proliferation in KO mouse epidermis ( Supplementary Fig. 1 , see also Fig 2C) . Reduced proliferation was not accompanied by changes in apoptosis, as examined by caspase 3 cleavage which was undetectable both in Wt and TRdeficient mice ( Supplementary Fig,3 ). To further characterize the role of TRs in epidermal function and proliferation, we examined the response of mice to topical application of TPA, a tumor promoter known to induce epidermal hyperplasia. After a topical dose of TPA the number of cell layers in wild-type (Wt) skin increased significantly within the first 24 h, whereas TPA-treated KO skin did not display a detectable hyperplasia. A strongly reduced hyperplasia in mice lacking TRs was also observed after 1 week of treatment (Fig. 1) .
To study if thyroid hormone loss has a similar effect than the absence of TRs on skin proliferation, skin morphology before and after TPA treatment was also analyzed in animals treated with anti-thyroidal drugs for 4 months. No evident differences between the skin of Wt and hypothyroid (hT) mice treated with vehicle alone were found, although BrdU incorporation was also reduced in these animals ( Supplementary Fig. 1 ). As shown in Fig.  2A , after two topical doses of TPA a strong reduction in skin hyperplasia was observed in hypothyroid (hT) mice. To analyze if the reduced hyperplasia in these animals is a consequence of reduced keratinocyte proliferative activity, BrdU incorporation was examined in TPA-treated animals. As it can be seen in Fig. 2A , BrdU incorporation was strongly decreased in hT and KO mice with respect to Wt animals. Fig. 2B shows the quantification of skin thickness and interfollicular BrdU incorporation in vehicle and TPA-treated groups. Although vehicle-treated hT and KO animals have a detectable reduction in BrdU incorporation, differences in skin thickness with respect to Wt mice were not found. However, after TPA treatment epidermal thickness was reduced to a similar extent in KO and hT mice with respect to Wt. In Wt mice approximately 3% of the interfollicular basal cells were labeled, and this index was significantly reduced in hT and KO groups. Furthermore, after two topical doses of TPA the BrdU labeling index in basal cells reached up to approximately 25% in WT mice while it was strongly reduced in animals lacking thyroid hormones or their receptors. All together, these findings clearly indicate that the hyperplastic response to TPA was reduced dramatically in hT and K.O mice, underscoring the important role of the liganded TRs in the proliferation of the mouse epidermis.
To investigate the possible molecular mechanisms responsible for the phenotypic alterations observed in the skin of TR KO mice, we examined by immunohistochemistry the expression of cyclin D1, a protein that plays a key role in skin proliferation (37) . Cyclin D1 expression was very low in vehicle-treated skins (not shown), but it is increased after TPA treatment in basal cells of Wt animals (Fig.  2C ), in agreement with the proliferation index found under these conditions. In addition, the reduced proliferation observed in hT and KO (Fig. 4) . The signaling cascades activated by these kinases control the expression of cell cycle molecules. Therefore, we also analyzed total and nuclear levels of AP-1 components and several cyclin kinase inhibitors (CKIs) that are crucial regulatory proteins for cell proliferation (Fig. 5) . AP-1 is a dimeric transcription factor complex consisting of homo-and heterodimers of the Jun and Fos protein families (40) . Expression of c-Jun is regarded as a positive regulator of keratinocyte proliferation in skin, whereas JunB can antagonize proliferation of keratinocytes (41) (42) (43) . Despite the reduced proliferative response, c-Jun and c-Fos levels were significantly elevated in the skin of the KO mice. Interestingly, this increase was detected mainly in the nuclear compartment in the case of c-Jun, whereas total c-Fos levels were preferentially elevated, showing that lack of TRs can affect differentially expression and subcellular localization of these proteins. On the other hand, basal JunB levels were higher in the nuclei from KO mice, and an earlier and stronger induction by TPA, which could at least partially counteract the functional effects of increased c-Jun levels, was also found. When AP-1 complexes were analyzed in EMSA assays, it could be observed that in Wt mice the abundance of proteins that bind a consensus AP-1 site is transiently increased by TPA reverting at 1 week of treatment, whereas in mice lacking TRs they were high in the absence of the tumor promoter and remained high even after 1 week, in agreement with the elevated levels of Jun proteins found in these animals ( Supplementary Fig. 4) .
When skin expression of CKIs was examined, it was observed that whereas the level of p21 was not significantly different between Wt and KO mice, the total levels of p27 were higher in the skin of the mice lacking TRs, and a very strong increase of p19 was found in the nuclei of these animals, suggesting that enhanced expression of cell cycle inhibitors could also contribute to the reduced proliferative response observed in the absence of TRs (Fig. 5, and Supplementary Fig. 5 ).
Increased production of proinflammatory cytokines and chemokines in the skin of TR KO mice. Topical application of TPA on the mouse skin not only induces hyperplasia, but it is also a well-known model for induction of cutaneous inflammation (32, 33) . We thus sought to analyze the skin inflammatory response in TR KO mice. With this purpose, we measured the levels of chemokines and proinflammatory cytokines, which play pivotal roles in the recruitment of inflammatory cells, in the skin of vehicle-and TPA-treated Wt and KO mice using cytokine arrays. Many of the assayed proteins presented changes between both groups (Fig. 6) . Some of them (CXCL1, CXCL2, CCL2 or TREM1) increased after TPA treatment in KO but not in WT animals, and others such as GM-CSF, CXCL10, CXCL11, CCL12 and CCL17 that increased in response to TPA in WT mice, were already elevated in vehicle-treated KO mice. Only one protein CCL11 responded to TPA in the Wt but not in KO mice (Fig. 6A) . The more relevant changes were found with the interleukins IL-3, IL-4, IL-6, IL-7 and the tumor necrosis factor α (TNFα). The levels of these cytokines, which were strongly stimulated by the tumor promoter in the Wt animals, were also significantly higher under basal conditions in vehicletreated KO skin when compared with the normal skin (Fig. 6B) . These results suggests that the mice lacking TRs present biochemical signs of skin inflammation and in agreement with this idea, the number of dermal cells was increased in the KO mice (Fig. 6C and Fig. 7A ). Increased infiltration of inflammatory cells in TR deficient animals was demonstrated by immunoflorescence analysis of skins performed with antibodies recognizing Mac1, CD3ε and CD45 (Fig. 7B) . Therefore, these receptors appear to play a physiological role as endogenous inhibitors of cutaneous inflammation.
Increased phosphorylation of p65/NF-κB and STAT3 in skin of mice lacking TRs.
Given that quite a few of the analyzed cytokines are controlled by the transcription factors NF-κB, STAT3 or both (44), our results suggest that TR deletion could increase the expression and/or activity of these factors. NF-κB transcription factors are bound in the cytoplasm to inhibitory proteins called IκBs, and their activation is commonly mediated by the IκB kinase (IKK) complex.
IKK-mediated IκB phosphorylation leads to their ubiquitindependent degradation and the subsequent nuclear entry of the released NF-κB dimers (45) . Once in the nucleus, transcriptional activity of NF-κB dimers can be further stimulated by protein phosphorylation (46, 47) . To analyze NF-κB status, we first prepared nuclear skin extracts from control and KO mice and assayed their NF-κB-binding complexes by EMSA. In mouse skin NF-κB complexes consists mainly of p50 homodimers and contains also p50/p65 heterodimers as identified by supershift assays ( (48) and Supplementary Fig. 6 ). Basal NF-κB binding was detected in the skin of both Wt and KO animals, and this binding increased similarly after topical application of TPA in both groups (Fig.  8A) . These results suggest that expression of NF-κB proteins was not altered by TR deletion, and in agreement with this idea the nuclear levels of p50, p65, IκB-α and IKKα were not changed in the KO mice (Fig. 8B) . In contrast, the levels of phosphorylated p65 were significantly higher in these mice, indicating that TRs do not decrease nuclear NF-κB content, but rather negatively interfere with p65 activation in the skin.
Activation of STAT3, which belongs to the signal transducer and activator of transcription (STAT) family of signal responsive transcription factors, is mediated by phosphorylation of a critical tyrosine residue (Tyr705) that induces STAT3 dimerization (49) . As illustrated in Fig. 8B , phosphorylation of STAT3 was strongly augmented upon TPA treatment in the skin of KO mice. In addition, STAT3 transcriptional activity and DNA binding can be further enhanced through serine (Ser727) phoshorylation (50) , and this phosphorylation was more sustained in skin from the mice lacking TRs. According to these results, the TR anti-inflammatory action in skin could be at least in part, due to the interference of this receptor with NF-κB and STAT3 activation.
Decreased proliferation and increased inflammatory mediators in primary keratinocytes from TR KO mice.
In order to analyze if the reduced skin proliferation observed in the KO mice is the result of a direct effect of the TRs on the keratinocytes, we analyzed BrdU incorporation in primary cultures of keratinocytes isolated from skin of newborn Wt and KO mice. As illustrated in Fig. 9A , the keratinocytes that lack TRs show an intrinsic proliferative defect since BrdU incorporation was reduced by 40% with respect to that found in the cultured keratinocytes from Wt mice. In agreement with the results obtained in vivo in the skin, despite presenting reduced proliferation, cultured keratinocytes from TR deficient mice had higher levels of AP-1 complexes than those of Wt mice, measured in gel retardation assays (Fig,  9B ). After incubation with TPA, AP-1 complexes increased transiently in Wt keratinocytes but not in KO cells. c-Jun levels followed a similar pattern, since the basal levels of this protein were also strongly increased in KO keratinocytes and they did not increase further upon TPA treatment. The levels of JunB and p27 were also constitutively elevated in the KO keratinocytes. c-Fos levels were low in unstimulated cells, but a stronger induction by TPA was also found in cultured keratinocytes from TR-deficient mice. On the other hand, and in contrast with the results obtained in vivo, cyclin D1 was not induced by the tumor promoter in the primary cultures and rather cyclin D1 levels were reduced, being this reduction observed earlier in the KO keratinocytes (Fig.9B ) In addition, there was an increase in the mRNA levels of TNFα in the KO cultures, in line with the higher levels of this cytokine observed in vivo in the skin of these animals (Fig. 9B) . Moreover, TNFα activates expression of the proinflammatory S100A8 and S100A9 proteins in primary keratinocytes (51) , and the transcripts for both proteins were also higher in the KO keratinocytes (Fig. 9C ). S100A8 and S100A9 proteins are potent stimulators of neutrophiles and are a hallmark of numerous pathological conditions associated with inflammation (52, 53) . The observed increase of inflammatory mediators in the cultured keratinocytes from TR-deficient mice was also accompanied by increased STAT3 and p65 phosphorylation (Fig. 9D) , reinforcing the idea that regulation of the activity of these transcription factors cold be involved in the effect of TRs on skin inflammation.
Finally, and in agreement with the results obtained in the skin in vivo, the nuclear levels of p19 were significantly upregulated in primary keratinocytes from TR KO mice (Fig. 9D) .
DISCUSSION
In this work we present evidence that the thyroid hormone receptors play an important role in skin proliferation. Although both skin structure and epidermal thickness appear to be normal en mice lacking TRα1 and TRβ genes, coding for the receptor isoforms able to bind thyroid hormone have been genetically inactivated, a significant reduction in BrdU incorporation in the interfollicular epidermis is observed in these animals under normal conditions. Furthermore, this difference is augmented after treatment with the hyperproliferative agent TPA. TR KO mice show a strongly reduced epidermal proliferation in response to the tumor promoter, indicating that they may be less sensitive to a two-stage skin carcinogenesis protocol. Indeed, we have previously reported that they develop fewer tumors than Wt mice when subjected to that protocol, although the tumors formed become more aggressive after chronic TPA treatment (13) . Since the proliferative defects observed in the skin of mice lacking TRs could be secondary to systemic effects or to changes in dermal fibroblasts rather than being mediated by direct effects on the keratinocytes, we also carried out studies with primary cultures of keratinocytes obtained from control and TR KO mice. Under these conditions, which mimic skin hyperproliferative states, proliferation was also reduced indicating that keratinocytes are a direct target of these receptors.
Analysis of TR double KO mice has revealed that they not exhibit a phenotype identical to that of hypothyroid mice, a difference generally attributed to the fact that these receptors in the absence of ligand can act as constitutive repressors because they bind corepressors that can specifically silence gene expression (54) . However, our results show that skin proliferation was similarly reduced in KO and hypothyroid mice, indicating that receptor loss is equivalent to ligand loss in this tissue and that therefore thyroid hormone binding to TRs rather than the effect of the corepressor-bound receptors mediates their actions on skin proliferation. These results are in agreement with the previous observation that topical application of the thyroid hormone triiodothyronine (T3) stimulates epidermal proliferation in rodents (30) . On the other hand, distinct phenotypes are found in mice in which TRα1 (9,10) are individually deleted and when both genes are inactivated, an array of phenotypes, not found in the single receptor-deficient mice are observed (11) , indicating that TRα1 and TRβ can substitute for each other to mediate some actions of the thyroid hormones but they can also mediate isoform-specific functions (54) . Our results show that TR isoforms can play overlapping functional roles in the skin, since single KO mice also present a proliferative defect but not as marked as that found in double KO mice.
The reduced epidermal proliferation observed in mice lacking TRs is accompanied by a strong reduction in cyclin D1 expression. Since this protein plays a key role in epidermal proliferation (37, 55) , this decrease could be an important component of the observed phenotype. Additionally, the increased expression of CKIs in the epidermis of mutant mice can also contribute to the proliferative defect found. Since ERK and AKT are essential for skin proliferation and cyclin D1 expresssion (38, 39, 56) , it would be expected a reduced activity of these kinases in TR KO mice, but paradoxically stimulation rather than inhibition was found in these animals, indicating that other still unidentified pathways dependent on the receptors are responsible for the reduction of cyclin D1. Since expression of the cyclin D1 gene is under the control of a panoply of transcription factors that are modulated by these kinases, the reduced cyclin D1 expression observed could indicate that the TRs and its ligand are required for the activity of those transcription factors, or that they are essential direct modulators of cyclin D1 expression in keratinocytes. In contrast, we and others have previously shown that TRs can inhibit expression of the cyclin D1 gene in other types of cells in culture through interference with the activity of transcription factors that bind to its promoter (4, 57, 58) . In addition, one may consider that the moderate increase in ERK and AKT activity found in KO mice was insufficient to allow for stimulation of cyclin D1 expression. In support of this possibility in KO mice we have not observed the alterations in ectodermal organ development mediated by expression of active AKT kinase in transgenic mouse epidermis (59) . However, we have observed a preferential increase in total vs nuclear p27 content in these mice, in agreement with the cytoplasmic localization of p27 mediated by AKT phosphorylation observed in cancer cells (60) . It is clear that the study of the mechanisms by which TR or thyroid hormone depletion reduces cyclin D1 expression in keratinocytes in vivo warrants further investigation.
In contrast with the dissociation between ERK and AKT activation and cyclin D1 expression, other targets of the MAPK cascade are enhanced in the skin of the TR KO mice. Thus, ERK activates AP-1 transcription factor complex expression and accordingly we found increased c-Fos and Jun proteins in the absence of TRs both in vivo and in cultured keratinocytes. These receptors are known to oppose AP-1 activity (2) and this observation agrees with this antagonism. Since both c-Jun and JunB that play opposite roles in proliferation (41) (42) (43) 61) were increased in the KO mouse, over-expression of JunB could also counteract the proliferative effects of c-Jun. Furthermore, ERK and Akt have been identified as important regulators of NF-κB activation in the skin (48, 62, 63) and consistent with this we found that p65 phosphorylation was increased in the TR KO mice.
Activation of NF-κB plays a key role in inflammatory skin processes (64, 65) and TPA is a potent activator of this factor as well as the transcription factor STAT3 (50, (66) (67) (68) . In addition to p65/NF-κB phosphorylation, we found that mice lacking TRs presented enhanced levels of STAT3 phosphorylation. Prominent amongst STAT3 and NF-κB targets are genes encoding cytokines and chemokines that play pivotal roles in the recruitment of inflammatory cells (44) . Furthermore, STAT3 induces the members of AP-1 family, and Jun proteins also enhance the expression of cytokines and chemotactic proteins (43) . Hence, the upregulation of NF-κB, STAT3 and AP-1 activity in the skin of TR KO mice should induce expression of inflammatory mediators, and accordingly a significant increase in the production of an important number of cytokines and chemokines, together with increased infiltration of inflammatory cells, was found in these animals. Remarkably, some of these proteins were overexpressed in the untreated animals, indicating that in the absence of TRs the skin already presents an inflammatory reaction under basal conditions. The ability of several members of the nuclear receptor superfamily to inhibit transcriptional activation by NF-κB and AP-1 by a mechanism that is referred to as transrepression, thereby, attenuating inflammatory responses is well known (69) . Our present results showing increased activity of these transcription factors as well as augmented production of proinflammatory molecules in TR KO mice demonstrate that TRs share these properties and that these receptors act as an endogenous brake of skin inflammation in vivo. At least some of the effects of TRs are directly exerted in the keratinocytes, as TNF-α expression is enhanced in primary cultures from mice lacking the receptors and activation of STAT3 and p65 was found in these cells. Furthermore, the chemotatic proteins S100A8 and S100A9 are also higher in the KO keratinocytes. These proteins are markedly overexpressed under cellular stress conditions and may play a role in the pathogenesis of epidermal disease and inflammation (52, 53) . Thus, the increased release of S100A8 and S100A9 from keratinocytes might be one important molecular event that could contribute to increased immune cell invasion and skin inflammation in TR KO mice.
In summary, the use of mice in which the TR isoforms that bind thyroid hormones have been inactivated, allows the definition of these nuclear receptors and its ligand as important components of the skin homeostasis in vivo. Interestingly, although cutaneous proliferation and inflammation are normally associated, in the absence of TRs there is a clear dissociation between both processes, since reduced proliferation together with an increased inflammatory response is found in the skin of animals in which TRs have been inactivated. Future studies will be needed to validate which of the changes of the analyzed molecules play a causal role in the epidermal phenotype observed upon loss of TR signalling, and which of them are the result of feedback mechanisms caused by those primary alterations. A more profound knowledge of the molecular mechanisms responsible for these actions will help to a better understanding of skin biology and thyroid diseases.
The abbreviations used are: hT, hypothyroid; KO, knock-out; TR thyroid hormone receptor, Wt: wild type Fig. 1 . Reduced hyperplasia after TPA treatment in mice lacking TRs. Dorsal skins of female wild-type mice (Wt) and double knockout mice lacking TRα1 and TRβ (KO), were treated topically with vehicle (acetone) or with TPA and sacrificed at the indicated time periods. H&E staining shows that epidermal hyperplasia was greatly reduced in KO skin. Epidermal thickness is indicated with brackets. Immunoblotting using whole-cell extracts from dorsal skin of wild-type (Wt) and TRα1 and TRβ knockout mice (KO) that were treated with TPA for 0 hours, 2 hours, 6 hours, 1 day and 1 week to check the expression of total and phosphorylated AKT and ERK. Each band represents a pool from 3 individual animals. 
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